Remove Packaging Remove Pharma Companies Remove Pharmaceutical Companies Remove Treatment
article thumbnail

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

A good part of half of those are within pharma. The weakness connected to that is we have so few large pharmaceuticals. Testa Center CEO Jesper Hedberg has been involved with the organisation since its inception and is a keen advocate of helping companies traverse the pharmaceutical development process.

Science 130
article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. A: Yes, the EUA is just temporary.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Case study: Extracting tidy data from Open Targets Genetics with Otargen

The Open Targets Blog

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. This is where our idea for an R package came from.  The package has three main functionalities: schema query functions, custom query functions, and plotting functions.

article thumbnail

Scaling Phage Therapy

Codon

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 138
article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. used in patient intake forms can influence clinical decisions or treatment protocols. Patients receiving cancer treatments prefer to get clinical support closer to their homes.

Research 130